SARM1 and colitis: Despite its positive effect of blocking the pathological degeneration of catecholaminergic axons, we were surprised to observe that the Sarm1 deletion significantly exacerbated the colitis condition, as evidenced by the worsened body-weight loss and disease activity index (Fig. 4D and 4E).